This is a single-center, prospective, open-label, non-randomized clinical trial exploring
cellular therapy to facilitate immunosuppression withdrawal in liver transplant recipients.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)